Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diurnal variation of levofloxacin pharmacokinetics
2013-001976-39Phase 4Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin, sponsored by Centre for Human Drug Research. Primary endpoint: Variation in main pharmacokinetic parameters over 24 hours. Started Jun 2013; status: completed.
02
Drugs
levofloxacin
Beyond the preview
Go deeper on 2013-001976-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001976-39.